Alibaba Cloud Launches Global Apsara Developer Community
Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, has announced the launch of Apsara Developer Community, a new hub created to support global developers through an enhanced provision of diverse developer tools and resources. It aims to support the continuous growth of the developer community, while facilitating the further progress of the digital economy across markets.
“The developer community is an integral part of Alibaba Cloud’s ecosystem. We hope to grow together with our developers by providing the latest technologies, ecosystem resources and business collaboration opportunities,” said Selina Yuan, Vice President of Alibaba Group and President of Alibaba Cloud Intelligence International Business Unit.
New and Enhanced Community Resources, Competitions and Scholarship for Global Developers
Unveiled at Alibaba Cloud’s Global Developer Summit at Jakarta today, The Apsara Developer Community offers global developers resources and insights into the rising technology trends ranging from Web3, AI to digital intelligence. These resources include access to a slew of new development tools and latest projects, training materials and tutorials, forums and blogs, community events and competitions to showcase their application development, and other upskilling and networking opportunities.
The cloud leader also announced its latest competition, PolarDB Global Hackathon 2023 , to encourage developers to explore cloud-native database innovations. From now until February 28, participants can submit their projects and winners will be awarded with a total of US$30,000 in cash prizes.
In addition, Alibaba Cloud also unveiled the Alibaba SMART Scholarship , which aims to encourage students to join the developer community with cloud-based technologies and become local digital talents. During the first year of this annual scholarship program, 20 interns from universities will be recruited to join Alibaba Cloud’s local offices to gain more field experience.
New Solution to Facilitate Superapp Development
With the rise of superapps – apps that include a range of independently developed miniapps to cater for different user requirements – Alibaba Cloud also unveiled a new solution to help developers build superapps cost-effectively and efficiently. Leveraging Alibaba Cloud’s Enterprise Mobile Application Studio (EMAS), the solution aims to enable developers to swiftly build superapps with rich platform capabilities within hours, adding competitive advantages for global organisations and enterprises.
Derived from the best practices of Alibaba’s e-commerce superapps Taobao and Tmall, the comprehensive solution provides developers with a rich ecosystem, including components for app infrastructure and business features, containers for running miniapps, and services for DevOps and operations.
“We believe our proven technologies and experience in supporting successful superapps can be beneficial for worldwide developers who are looking to create their own superapps and corresponding platform ecosystem,” said Raymond Xiao, Head of International Industry Solutions and Architecture at Alibaba Cloud Intelligence. “We can co-create more innovative technologies and solutions together with our developers, boosting further growth of the developer community.”
Alibaba Cloud is dedicated to contributing to the developer ecosystem including the open-source community. Alibaba Cloud, with over 30,000 contributors, has contributed to over 2,700 open-source projects on Github. The leading cloud provider is also a key member in various open-source communities such as Cloud Native Computing Foundation (CNCF), The Linux Foundation and RISC-V International.
About Alibaba Cloud
Established in 2009, Alibaba Cloud (www.alibabacloud.com) is the digital technology and intelligence backbone of Alibaba Group. It offers a complete suite of cloud services to customers worldwide, including elastic computing, database, storage, network virtualization services, large-scale computing, security, management and application services, big data analytics, a machine learning platform and IoT services. Alibaba Cloud is China’s leading provider of public cloud services by revenue in 2019, including PaaS and IaaS services, according to IDC. Alibaba Group is the world’s third leading and Asia Pacific’s leading IaaS provider by revenue in 2020 in U.S. dollars, according to Gartner’s April 2021 report.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005670/en/
Contact information
Crystal Liu
E: Crystal.liu@alibaba-inc.com
P: +86 18578497650
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit28.4.2024 14:57:00 EEST | Press release
TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL), at Yas Marina Circuit on Saturday (April 27). As the cars lined up on the grid, with antennae, sensors, AI capabilities, and drive-by-wire systems instead of human drivers, eight teams vied with one another over two days of races and challenges. TUM beat back the competition with its coding and engineering skills in a world-first, four-car race finale, to claim the winner’s share of US$2.25 million prize pot. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428292385/en/ TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit - (Photo: AETOSWire) Bringing a science experiment to the racetrack, the inaugural race pushed the boundaries of autonomous technology while adding entertainment value to extreme sports at an unprecedented scale. A2RL drew over 10,000
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom